Psychiatry Research: Neuroimaging
Volume 173, Issue 2 , Pages 88-93 , 30 August 2009

Association between cerebral metabolic and structural abnormalities and cognitive performance in schizophrenia

  • Vicente Molina

      Affiliations

    • Dept of Psychiatry, Hospital Universitario, Salamanca, Spain
    • Corresponding Author InformationCorresponding author. Dept. of Psychiatry, Hospital Clínico Universitario, Paseo de San Vicente, 58-182, E-37007 Salamanca, Spain. Tel.: +34 923291102; fax: +34 923291383.
    • ,
  • Sara Solera

      Affiliations

    • Dept of Psychiatry, Hospital Doce de Octubre, Madrid, Spain
    • ,
  • Javier Sanz

      Affiliations

    • Dept of Psychiatry, Hospital Doce de Octubre, Madrid, Spain
    • ,
  • Fernando Sarramea

      Affiliations

    • Dept of Psychiatry, Hospital Reina Sofía, Córdoba, Spain
    • ,
  • Rogelio Luque

      Affiliations

    • Dept of Psychiatry, Hospital Reina Sofía, Córdoba, Spain
    • ,
  • Roberto Rodríguez

      Affiliations

    • Dept of Psychiatry, Hospital Doce de Octubre, Madrid, Spain
    • ,
  • Miguel Angel Jiménez-Arriero

      Affiliations

    • Dept of Psychiatry, Hospital Doce de Octubre, Madrid, Spain
    • ,
  • Tomás Palomo

      Affiliations

    • Dept of Psychiatry, Hospital Doce de Octubre, Madrid, Spain

Received 4 December 2007 ,Revised 19 July 2008 ,Accepted 23 September 2008.

References 

  1. Alvarez JA, Emory E. Executive function and the frontal lobes: a meta-analytic review. Neuropsychological Rehabilitation. 2006;16:17–42
  2. Ashburner J, Friston KJ. Multimodal image coregistration and partitioning — a unified framework. Neuroimage. 1997;6:209–217
  3. Buchsbaum MS. Positron emission tomography studies of abnormal glucose metabolism in schizophrenic illness. Clinical Neuroscience. 1995;3:122–130
  4. Callicott JH, Bertolino A, Mattay VS, Langheim FJ, Duyn J, Coppola R, et al. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited. Cerebral Cortex. 2000;10:1078–1092
  5. Cannon TD, Hennah W, van Erp TG, Thompson PM, Lonnqvist J, Huttunen M, et al. Association of DISC1/TRAX haplotypes with schizophrenia, reduced prefrontal gray matter, and impaired short- and long-term memory. Archives of General Psychiatry. 2005;62:1205–1213
  6. Cuesta MJ, Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Research. 1995;58:227–235
  7. Cuesta MJ, Peralta V, Zarzuela A. Illness duration and neuropsychological impairments in schizophrenia. Schizophrenia Research. 1998;33:141–150
  8. Dickinson D, Ramsey ME, Gold JM. Overlooking the obvious: a meta-analytic comparison of digit symbol coding tasks and other cognitive measures in schizophrenia. Archives of General Psychiatry. 2007;64:532–542
  9. Fuster JM. Synopsis of function and dysfunction of the frontal lobe. Acta Psychiatrica Scandinavica. Supplementum. 1999;395:51–57
  10. Goldberg TE, Weinberger DR. The effects of clozapine on neurocognition: an overview. Journal of Clinical Psychiatry. 1994;55:88–90(Suppl B)
  11. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophrenia Research. 2004;72:41–51
  12. Hollingshead A, Frederick R. Social stratification and psychiatric disorders. American Sociological Review. 1953;18:163–189
  13. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Research. 1987;13:261–276
  14. Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, et al. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology. 2004;29:171–178
  15. MacDonald AW, Carter CS, Kerns JG, Ursu S, Barch DM, Holmes AJ, et al. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. American Journal of Psychiatry. 2005;162:475–484
  16. Manoach DS, Press DZ, Thangaraj V, Searl MM, Goff DC, Halpern E, et al. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI. Biological Psychiatry. 1999;45:1128–1137
  17. Mesulam MM. Large-scale neurocognitive networks and distributed processing for attention, language, and memory. Annals of Neurology. 1990;28:597–613
  18. Molina V, Reig S, Sarramea F, Sanz J, Artaloytia JF, Luque R, et al. Anatomical and functional brain variables associated to clozapine response in treatment-resistant schizophrenia. Psychiatry Research: Neuroimaging. 2003;124:153–161
  19. Molina V, Gispert JD, Reig S, Pascau J, Palomo T, Martínez R, et al. Olanzapine-induced cerebral metabolic changes. Relation to symptom changes in schizophrenia. International Clinical Psychopharmacology. 2005;20:13–18
  20. Molina V, Sanz J, Reig S, Martínez R, Sarramea F, Luque R, et al. Hypofrontality in males with first-episode psychosis. British Journal of Psychiatry. 2005;186:203–208
  21. Molina V, Sarramea F, Sanz J, Benito C, Palomo T. Prefrontal atrophy in first episodes of schizophrenia associated with limbic hyperactivity. Journal of Psychiatric Research. 2005;39:117–127
  22. Molina V, Sanz J, Sarramea F, Luque R, Benito C, Palomo T. Dorsolateral prefrontal and superior temporal volume deficits in first episode psychosis that evolve into schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2006;256:106–111
  23. Nuechterlein KH, Barch DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophrenia Research. 2004;72:29–39
  24. Pfefferbaum A, Lim KO, Zipursky RB, Mathalon DH, Rosenbloom MJ, Lane B, et al. Brain gray and white matter volume loss accelerates with aging in chronic alcoholics: a quantitative MRI study. Alcoholism: Clinical and Experimental Research. 1992;16:1078–1089
  25. Rummel C, Hamann J, Kissling W, Leucht S. New generation antipsychotics for first episode schizophrenia. Cochrane Database of Systematic Reviews. 2003;CD004410
  26. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophrenia Research. 2001;49:1–52
  27. Sweeney JA, Haas GL, Li S. Neuropsychological and eye movement abnormalities in first-episode and chronic schizophrenia. Schizophrenia Bulletin. 1992;18:283–293
  28. Wechsler D. Wechsler Adult Intelligence Scale. Madrid: Ediciones TEA, S.A; 1999;
  29. Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends in Neurosciences. 2004;27:683–690
  30. Wolf RC, Vasic N, Hose A, Spitzer M, Walter H. Changes over time in frontotemporal activation during a working memory task in patients with schizophrenia. Schizophrenia Research. 2007;91:141–150
  31. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. Journal of Clinical Psychiatry. 2003;64:663–667
  32. Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. Journal of Computer Assisted Tomography. 1993;17:536–546

PII: S0925-4927(08)00151-0

doi: 10.1016/j.pscychresns.2008.09.009

Psychiatry Research: Neuroimaging
Volume 173, Issue 2 , Pages 88-93 , 30 August 2009

Article Tools

* Image Usage & Resolution